Ardea Biosciences, Inc. (RDEA) Misses Q1 Views
Ardea Biosciences, Inc. (Nasdaq: RDEA) reported Q1 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $3.86 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Properties (BXP) Reports In-Line Q3 FFO, Guides Above the Street
- Oritani Financial (ORIT) Tops Q1 EPS by 1c
- Logitech (LOGI) Tops Q2 EPS by 10c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!